Showing results (111-120 of 324) with videos related to

Sort By:
Pageof 33
Blood|September 12, 2012
Antigen and substrate withdrawal in the management of autoimmune thrombotic disordersDouglas B Cines, Keith R McCrae, X Long Zheng, et al.
Journal of Thrombosis and Thrombolysis|March 28, 2018
Management of antithrombotic therapy in adults with immune thrombocytopenia (ITP): a survey of ITP specialists and general hematologist-oncologistsAllyson M Pishko, Mudi Misgav, Adam Cuker, et al.
Blood|September 13, 2007
Determinants of PF4/heparin immunogenicityShayela Suvarna, Benjamin Espinasse, Rui Qi, et al.
American Journal of Physiology. Heart and Circulatory Physiology|May 28, 2013
Domain 2 of uPAR regulates single-chain urokinase-mediated angiogenesis through β1-integrin and VEGFR2Gretchen A Larusch, Alona Merkulova, Fakhri Mahdi, et al.
Molecular Immunology|August 20, 2018
Developments in anti-complement therapy; from disease to clinical trialClaire L Harris, Richard B Pouw, David Kavanagh, et al.
Expert Review of Hematology|September 13, 2014
Complement in paroxysmal nocturnal hemoglobinuria: exploiting our current knowledge to improve the treatment landscapeDimitrios C Mastellos, Daniel Ricklin, Despina Yancopoulou, et al.
The Journal of Biological Chemistry|August 13, 2002
Binding of urokinase to low density lipoprotein-related receptor (LRP) regulates vascular smooth muscle cell contractionTaher Nassar, Abdullah Haj-Yehia, Sa'ed Akkawi, et al.
Journal of Molecular Biology|September 19, 2006
Structural basis of interaction between urokinase-type plasminogen activator and its receptorCyril Barinka, Graham Parry, Jennifer Callahan, et al.
Pageof 33